India's Dr Reddy's expects healthy products pipeline in North America for FY25

India's Dr Reddy's Laboratories (REDY.NS) expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the generic drugmaker said on Tuesday, after it reported a fourth-quarter profit that beat expectations.